Mannkind (MNKD) Inventory Average (2015 - 2026)
Mannkind (MNKD) posted quarterly Inventory Average of $42.2 million for Q1 2026, up 48.79% year-over-year from $28.4 million in Q1 2025, and up 35.63% quarter-over-quarter from $31.1 million in Q4 2025.
Mannkind (MNKD) Inventory Average (2015 - 2026) Analysis & Trends
Mannkind (MNKD) has reported Inventory Average for 12 consecutive years, with $42.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average rose 48.79% year-over-year to $42.2 million; the TTM figure through Mar 2026 stood at $42.2 million (up 48.79% YoY), while the FY2025 annual figure was $31.6 million, up 11.99% from the prior year.
- Inventory Average rose to $42.2 million in Q1 2026 per MNKD's latest filing, from $31.1 million in the prior quarter.
- Across five years, Inventory Average topped out at $42.2 million in Q1 2026 and bottomed at $7.6 million in Q1 2022.
- Historically, Inventory Average has averaged $25.0 million across 5 years, with a median of $26.2 million in 2023.
- Annual changes were most pronounced in 2023 — Inventory Average surged 188.04% — and 2024, when it dropped 2.0%.
- Mannkind's Inventory Average stood at $20.0 million in 2022, then surged by 39.0% to $27.8 million in 2023, then slipped by 2.0% to $27.3 million in 2024, then rose by 14.18% to $31.1 million in 2025, then jumped by 35.63% to $42.2 million in 2026.
- Business Quant data shows MNKD's Inventory Average at $42.2 million in Q1 2026, $31.1 million in Q4 2025, and $27.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Mannkind | 1.19 Bn | 1.08 Bn | 94.97 Mn | 46.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 46.79 Mn |
| Mar 31, 2026 | 42.24 Mn |
| Dec 31, 2025 | 31.14 Mn |
| Sep 30, 2025 | 27.73 Mn |
| Jun 30, 2025 | 28.69 Mn |
| Mar 31, 2025 | 28.39 Mn |
| Dec 31, 2024 | 27.27 Mn |
| Sep 30, 2024 | 25.71 Mn |
| Jun 30, 2024 | 25.60 Mn |
| Mar 31, 2024 | 27.49 Mn |
| Dec 31, 2023 | 27.83 Mn |
| Sep 30, 2023 | 26.20 Mn |
| Jun 30, 2023 | 23.64 Mn |
| Mar 31, 2023 | 21.89 Mn |
| Dec 31, 2022 | 20.02 Mn |
| Sep 30, 2022 | 19.42 Mn |
| Jun 30, 2022 | 14.31 Mn |
| Mar 31, 2022 | 7.60 Mn |
| Dec 31, 2021 | 7.32 Mn |
| Sep 30, 2021 | 7.48 Mn |